Ownership history in Frazier Life Sciences Management, L.P. · 16 quarters on record
This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in MIRUM PHARMACEUTICALS INC (MIRM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 6,795,121 | — | 0% | 14.42% | $536.7M | $78.99 |
| 2025 Q3 | UNCHANGED | 6,795,121 | — | 0% | 14.93% | $498.2M | $73.31 |
| 2025 Q2 | UNCHANGED | 6,795,121 | — | 0% | 13.83% | $345.8M | $50.89 |
| 2025 Q1 | ADDED | 6,795,121 | +224,729 | +3.4% | 13.99% | $306.1M | $45.05 |
| 2024 Q4 | UNCHANGED | 6,570,392 | — | 0% | 11.28% | $271.7M | $41.35 |
| 2024 Q3 | ADDED | 6,570,392 | +75,000 | +1.2% | 10.27% | $256.2M | $39.00 |
| 2024 Q2 | UNCHANGED | 6,495,392 | — | 0% | 10.39% | $222.1M | $34.19 |
| 2024 Q1 | UNCHANGED | 6,495,392 | — | 0% | 6.88% | $163.2M | $25.12 |
| 2023 Q4 | ADDED | 6,495,392 | +25,000 | +0.4% | 10.25% | $191.7M | $29.52 |
| 2023 Q3 | ADDED | 6,470,392 | +2,110,285 | +48.4% | 13.58% | $204.5M | $31.60 |
As of 2025 Q4 — sorted by position size